HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $493,926 | +1.4% | 12,930 | -4.3% | 0.00% | 0.0% |
| Q2 2023 | $487,125 | +20.0% | 13,505 | +26.9% | 0.00% | 0.0% |
| Q1 2023 | $406,000 | -20.9% | 10,642 | +17.9% | 0.00% | -33.3% |
| Q4 2022 | $513,579 | +2.3% | 9,026 | -28.9% | 0.00% | 0.0% |
| Q3 2022 | $502,000 | +17.8% | 12,689 | +31.2% | 0.00% | +50.0% |
| Q2 2022 | $426,000 | -78.9% | 9,673 | -79.6% | 0.00% | -81.8% |
| Q4 2020 | $2,022,000 | -10.2% | 47,332 | -44.8% | 0.01% | -15.4% |
| Q3 2020 | $2,252,000 | -5.0% | 85,700 | -3.1% | 0.01% | -13.3% |
| Q2 2020 | $2,371,000 | -34.9% | 88,453 | -56.3% | 0.02% | -44.4% |
| Q1 2020 | $3,642,000 | – | 202,457 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |